It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Paeniclostridium sordellii lethal toxin (TcsL) is a potent exotoxin that causes lethal toxic shock syndrome associated with fulminant bacterial infections. TcsL belongs to the large clostridial toxin (LCT) family. Here, we report that TcsL with varied lengths of combined repetitive oligopeptides (CROPs) deleted show increased autoproteolysis as well as higher cytotoxicity. We next present cryo-EM structures of full-length TcsL, at neutral (pH 7.4) and acidic (pH 5.0) conditions. The TcsL at neutral pH exhibits in the open conformation, which resembles reported TcdB structures. Low pH induces the conformational change of partial TcsL to the closed form. Two intracellular interfaces are observed in the closed conformation, which possibly locks the cysteine protease domain and hinders the binding of the host receptor. Our findings provide insights into the structure and function of TcsL and reveal mechanisms for CROPs-mediated modulation of autoproteolysis and cytotoxicity, which could be common across the LCT family.
Paeniclostridium sordellii lethal toxin (TcsL) is a potent toxin that can cause toxic shock syndrome. TcsL contains a unique CROPs domain with unclear functions. Here, the authors provide evidence of the CROPs domain’s role in stability and toxicity of TcsL.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Westlake Laboratory of Life Sciences and Biomedicine, Center for Infectious Disease Research, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315); School of Life Sciences, Westlake University, Key Laboratory of Structural Biology of Zhejiang Province, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315); Westlake Institute for Advanced Study, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315); Westlake University, Research Center for Industries of the Future, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315)
2 Westlake Laboratory of Life Sciences and Biomedicine, Center for Infectious Disease Research, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315); School of Life Sciences, Westlake University, Key Laboratory of Structural Biology of Zhejiang Province, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315); Westlake Institute for Advanced Study, Hangzhou, China (GRID:grid.494629.4) (ISNI:0000 0004 8008 9315)